Like doctors who have been using VR to assist in surgeries and pinpoint ailments — by generating 3D models of
real patient tumors from MRI scans, for example — science teachers are saying VR can help deepen understanding of subjects such as biology and anatomy, which require students to grasp the inner workings of cells and organs that are not visible to the human eye.
Not exact matches
«For
patients who have not responded to prior therapies, this drug now provides a very
real chance to shrink their
tumors and the hope of a lasting response to treatment.»
A newly devised
tumor - specific fluorescent agent and imaging system guided surgeons in
real time to remove additional
tumors in ovarian cancer
patients that were not visible without fluorescence or could not be felt during surgery, reports Alexander L. Vahrmeijer MD, PhD, head of the Image - guided Surgery group in the Department of Surgery at Leiden University Medical Center in the Netherlands.
Because a
tumor's RNA shows the
real time changes a treatment is causing, the authors think this could be a useful tool to aid diagnosis and predict which treatment will most benefit individual cancer
patients.
The technology successfully tracked in
real - time how the diversity of
tumor cell populations were changing in response to particular therapies for all of the
patients studied, and was highly predictive of treatment effectiveness and
patient outcomes.
The first manuscript entitled, Circulating Free
Tumor - derived DNA (ctDNA) Determination of EGFR Mutation Status in
Real - World European and Japanese
Patients with Advanced NSCLC: the ASSESS Study, used samples from the large ASSESS study to evaluate EGFR mutation status by analyzing ctDNA from blood plasma.
Atul Butte, PhD, who is Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF and directs the Institute for Computational Health Sciences, a hub for precision medicine research on campus, echoed the excitement felt across UCSF about moving towards clinical application of precision medicine: «Precision medicine is not just a «nice idea» at UCSF — it is benefitting
real people, from cancer
patients with unusual
tumor mutations to children with undiagnosed genetic diseases.
Paris Descartes APHP and INSERM Poster # / Location: 4546 / Section 25, Board 1 Hyperlink: http://www.abstractsonline.com/pp8/#!/4562/presentation/7648 The
tumor inflammation signature (TIS) and other gene expression signatures, simultaneously analyzed using the IO 360 panel, predict clinical benefit of anti-PD1 treatment (nivolumab and pembrolizumab) in «
real life»
patients with various cancer types, including NSCLC.